Research interfacing chemical biology with the -omic sciences and systems biology.
Impact Factor 3.183 12 Issues per Year Indexed in MEDLINE
Review Article

Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Department of Radiation Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
b
Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B13, Bethesda, USA
E-mail: hodgej@mail.nih.gov;
Fax: +1 (301) 496-2756 ;
Tel: +1 (301) 496-0631
Mol. BioSyst., 2009,5, 1262-1270

DOI: 10.1039/B911313B
Received 09 Jun 2009, Accepted 17 Jul 2009
First published online 27 Aug 2009

This article is part of themed collection: Molecular BioSystems Review Articles in Chemical Biology
| | | | | | More
Please wait while Download options loads
Download Citation